Related Experiment Video
Updated: Aug 20, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Effects of digitalis on resting and isometric exercise myocardial perfusion in patients with coronary artery disease
Insights
Digitalis improves myocardial perfusion in patients with coronary artery disease and left ventricular dysfunction. This study found that digoxin enhanced thallium-201 uptake during exercise, suggesting better blood flow to the heart muscle.
Area of Science:
- Cardiology
- Nuclear Cardiology
- Pharmacology
Background:
- Coronary artery disease (CAD) often impairs ventricular function.
- Digitalis has known effects on cardiac function, including improved contractility and potential for vasoconstriction.
- The net effect of digitalis on myocardial perfusion in CAD patients with dysfunction is not fully understood.
Purpose of the Study:
- To investigate the impact of digoxin on myocardial perfusion during exercise in patients with CAD and left ventricular dysfunction.
- To determine if digoxin mitigates exercise-induced reductions in myocardial perfusion.
Main Methods:
- Six patients with CAD and ejection fractions <0.50 were studied.
- Thallium-201 scintigraphy was performed at rest and during handgrip exercise, both with and without maintenance digoxin.
- Scintigram images were computer-processed and visually graded to assess myocardial perfusion.
Main Results:
- Handgrip exercise decreased scintigram scores (indicating reduced perfusion) in patients not taking digoxin (25.7 to 23.0, P<0.05).
- Digoxin administration prevented significant changes in scintigram scores during exercise.
- Post-exercise scores were significantly higher with digoxin compared to without (P<0.05).
- Resting scores were not significantly affected by digoxin.
Conclusions:
- Myocardial perfusion, assessed by thallium-201 uptake, appears to be improved by digitalis in patients with CAD and left ventricular dysfunction.
- Digoxin may preserve or enhance myocardial blood flow during stress in this patient population.
Abstract:
Digitalis has been shown to improve the impaired ventricular function associated with coronary artery disease as well as to increase myocardial oxygen consumption and produce coronary vasoconstriction. To elucidate the net result of these contrasting effects, six patients with coronary artery disease and left ventricular ejection fractions less than 0.50 had 1.0 mCi thallium-201 injected intravenously at rest and during three minutes of 33% of maximal handgrip, off and on 0.25 mg daily maintenance digoxin. Thallium-201 scintigram images were taken 30 minutes later and were computer processed with orthogonal linearly interpolated background subtraction and maximal count density equalization. Processed images were visually graded on a 0, 1, or 2 scale for 18 sectors--nine from the AP projections and nine from the 40 degrees left anterior oblique projections. A score resulting from the summation of the 18 sector grades was made for each study, the maximum score being 36. Off digitalis, patients performing handgrip exercise decreased their scintigram scores from 25.7 +/- 1.5 (mean +/- SEM) to 23.0 +/- 1.0, P less than 0.05. When patients were on maintenance digoxin, scores did not change significantly during handgrip exercise. Post exercise scores were significantly higher on digoxin than off (P less than 0.05), whereas, resting scores were unaffected by digoxin. These data suggest that myocardial perfusion, as measured by thallium-201 uptake, is improved in patients on digitalis who have coronary artery disease and left ventricular dysfunction.
More Related Videos
Related Concept Videos
Pathophysiology of Cardiac Performance
Heart Failure Drugs: Inotropic Agents
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

